New White Paper Challenges Thyroid Cancer Risks from GLP-1 Medications Amid Rising Usage A new white paper from the Clayman Thyroid Center debunks fears linking GLP-1 medications like Ozempic and Wegovy to thyroid cancer risk, backed by scientific evidence.

New White Paper Challenges Thyroid Cancer Risks from GLP-1 Medications Amid Rising Usage #USA #Tampa #GLP-1_Medications #Clayman_Thyroid_Center #thyroid_cancer

Clayman Thyroid Center Introduces Hashimoto's Disease Awareness Day for Greater Understanding and Advocacy The Clayman Thyroid Center launches Hashimoto's Disease Awareness Day to educate and empower those affected by the condition, promoting early diagnosis.

Clayman Thyroid Center Introduces Hashimoto's Disease Awareness Day for Greater Understanding and Advocacy #USA #Tampa #Awareness_Day #Hashimoto's_Disease #Clayman_Thyroid_Center